Precision Biosensor, Inc. (KOSDAQ: 335810)

Market Cap	35.71B
Revenue (ttm)	17.14B
Net Income (ttm)	-6.81B
Shares Out	11.61M
EPS (ttm)	-586.22
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,971
Open	3,100.00
Previous Close	2,945.00
Day's Range	2,915.00 - 3,100.00
52-Week Range	2,910.00 - 7,110.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2024

About Precision Biosensor

Precision Biosensor, Inc., an in-vitro diagnostics company, manufactures, distributes, and sells diagnostic reagents and analyzing devices in South Korea. The company offers cartridges for cardiac, infection, and brain, as well as colorectal, pregnancy, and vitamin D deficiency indications; and immunochromatographic analyzers. It also provides thermostat devices for activating the reagent reactions; and IQC analyzers. The company was founded in 2015 and is headquartered in Daejeon, South Korea.

• Industry: Measuring and Controlling Devices, not elsewhere classified
• Founded: 2015
• Employees: 102
• Stock Exchange: KOSDAQ
• Ticker Symbol: 335810

Financial Performance

In 2023, Precision Biosensor's revenue was 20.39 billion, a decrease of -0.33% compared to the previous year's 20.46 billion. Losses were -4.49 billion, -34.02% less than in 2022.